Structures by: Pallipurath A. R.
Total: 45
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.0907(3)Å b=11.5779(4)Å c=22.8104(7)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.0785(2)Å b=11.5265(3)Å c=22.8581(6)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.1349(3)Å b=11.6868(4)Å c=22.8660(8)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.0963(2)Å b=11.5574(3)Å c=22.8612(7)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.1445(3)Å b=11.7130(3)Å c=22.8862(5)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.1415(4)Å b=11.7002(4)Å c=22.8837(6)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.1357(3)Å b=11.6782(3)Å c=22.8834(6)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.1405(3)Å b=11.6923(2)Å c=22.8838(4)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.1280(3)Å b=11.6579(3)Å c=22.8759(5)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.1311(3)Å b=11.6667(2)Å c=22.8800(4)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.1200(3)Å b=11.6339(3)Å c=22.8697(4)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.1158(2)Å b=11.6222(2)Å c=22.8715(3)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.1066(2)Å b=11.5983(2)Å c=22.8627(3)Å
α=90.00° β=90.00° γ=90.00°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.1070(3)Å b=11.5902(3)Å c=22.8593(6)Å
α=90.00° β=90.00° γ=90.00°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.1064(3)Å b=11.5845(3)Å c=22.8569(6)Å
α=90.00° β=90.00° γ=90.00°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.1048(3)Å b=11.5802(3)Å c=22.8576(6)Å
α=90.00° β=90.00° γ=90.00°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.0992(4)Å b=11.5635(3)Å c=22.8525(6)Å
α=90.00° β=90.00° γ=90.00°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.0972(2)Å b=11.5751(2)Å c=22.8531(3)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.0881(3)Å b=11.5538(2)Å c=22.8478(3)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.0823(3)Å b=11.5422(2)Å c=22.8439(3)Å
α=90.00° β=90.00° γ=90.00°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.1228(4)Å b=11.6522(6)Å c=22.8488(10)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.1074(3)Å b=11.6193(5)Å c=22.8456(9)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.0885(6)Å b=11.5482(7)Å c=22.7898(12)Å
α=90° β=90° γ=90°
C11H12N4O2S
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.4973(2)Å b=8.21180(10)Å c=21.9658(3)Å
α=90° β=90° γ=90°
C11H12N4O2S
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.5008(2)Å b=8.21410(10)Å c=21.9821(4)Å
α=90° β=90° γ=90°
C11H12N4O2S
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.49500(10)Å b=8.20940(10)Å c=21.9489(3)Å
α=90° β=90° γ=90°
C11H12N4O2S
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.49140(10)Å b=8.20690(10)Å c=21.9332(3)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.48840(10)Å b=8.20480(10)Å c=21.9167(3)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.48520(10)Å b=8.20200(10)Å c=21.9002(3)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.48140(10)Å b=8.19930(10)Å c=21.8844(3)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.47950(10)Å b=8.19740(10)Å c=21.8693(3)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.4763(2)Å b=8.19460(10)Å c=21.8522(4)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.47010(10)Å b=8.18890(10)Å c=21.8216(4)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.47340(10)Å b=8.19210(10)Å c=21.8397(3)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.46380(10)Å b=8.18350(10)Å c=21.7953(2)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.45970(10)Å b=8.18020(10)Å c=21.7812(2)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.4902(9)Å b=8.2249(6)Å c=22.0106(14)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.45880(10)Å b=8.18000(10)Å c=21.7664(2)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.4899(5)Å b=8.2086(4)Å c=21.9106(9)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.4829(6)Å b=8.1938(3)Å c=21.8441(9)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.4687(6)Å b=8.1829(9)Å c=21.8084(4)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.4393(7)Å b=8.1764(4)Å c=21.7395(13)Å
α=90.00° β=90.00° γ=90.00°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.1237(2)Å b=11.6442(2)Å c=22.8738(4)Å
α=90° β=90° γ=90°
C11H12N4O2S
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.5040(2)Å b=8.21620(10)Å c=21.9984(4)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.46660(10)Å b=8.18680(10)Å c=21.8103(2)Å
α=90° β=90° γ=90°